Published in Am J Kidney Dis on January 01, 2000
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis (2011) 2.01
Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis. Pediatr Nephrol (2010) 1.49
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. Nephrol Dial Transplant (2013) 1.07
Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study. Nephrol Dial Transplant (2008) 0.90
Health-related quality of life and all-cause mortality in patients with diabetes on dialysis. BMC Nephrol (2012) 0.90
Decline in residual renal function in automated compared with continuous ambulatory peritoneal dialysis. Clin J Am Soc Nephrol (2011) 0.88
Age-related differences in the quality of life in end-stage renal disease in patients enrolled in hemodialysis or continuous peritoneal dialysis. Med Sci Monit (2013) 0.84
Content analysis and qualitative study of hemodialysis patients, family experience and perceived social support. Iran Red Crescent Med J (2014) 0.83
A self-report comorbidity questionnaire for haemodialysis patients. BMC Nephrol (2014) 0.82
Sites of peripheral artery occlusive disease as a predictor for all-cause and cardiovascular mortality in chronic hemodialysis. PLoS One (2015) 0.79
The association of mental health over time with cardiac outcomes in HEMO study patients. Clin J Am Soc Nephrol (2012) 0.79
Current techniques for assessment of upper extremity vasculature prior to hemodialysis vascular access creation. Eur Radiol (2007) 0.77
Quality of life during hemodialysis and study dialysis treatment in patients referred to teaching hospitals in Urmia-Iran in 2007. Caspian J Intern Med (2011) 0.77
Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease. PLoS One (2016) 0.75
Impact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa. BMC Nephrol (2016) 0.75
Strategies for the preservation of residual renal function in pediatric dialysis patients. Pediatr Nephrol (2013) 0.75
Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet (1998) 4.33
Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke (2001) 3.90
Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg (2000) 3.83
On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res (2003) 3.71
Travel time from home to hospital and adverse perinatal outcomes in women at term in the Netherlands. BJOG (2010) 2.62
Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology (2006) 2.46
Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int (2007) 2.42
Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart (1999) 2.40
Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis (1997) 2.37
SSEPs and prognosis in postanoxic coma: only short or also long latency responses? Neurology (2006) 2.31
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. J Thromb Haemost (2012) 2.17
Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax (2002) 2.09
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD) Nephrol Dial Transplant (1999) 2.04
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis (2007) 1.97
Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant (2001) 1.87
Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry (2001) 1.84
Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology (2008) 1.80
Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res (2002) 1.79
Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology (2007) 1.79
Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int (2006) 1.74
Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med (1999) 1.71
Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet (1999) 1.67
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Handicap questionnaires: what do they assess? Disabil Rehabil (1999) 1.60
Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology (2004) 1.58
Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost (1997) 1.56
Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia (2004) 1.56
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci (Lond) (1989) 1.53
The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clin Rehabil (1999) 1.51
Psychometric properties of the Impact on Participation and Autonomy Questionnaire. Arch Phys Med Rehabil (2001) 1.50
The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int (1994) 1.48
When to initiate dialysis: effect of proposed US guidelines on survival. Lancet (2001) 1.47
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review. Neurology (2002) 1.47
Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int (2000) 1.44
The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol (2003) 1.42
Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD. Nephrol Dial Transplant (1996) 1.41
[Epoetin-induced pure red-cell aplasia]. Ned Tijdschr Geneeskd (2004) 1.41
The burden of caregiving in partners of long-term stroke survivors. Stroke (1998) 1.41
Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int (1990) 1.40
Predialytic period and baseline peritoneal membrane status: any connection? Perit Dial Int (2010) 1.39
Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int (1998) 1.38
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol (1998) 1.38
Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int (1997) 1.37
Confounding: what it is and how to deal with it. Kidney Int (2007) 1.37
Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. Chest (1990) 1.36
Intraperitoneal administration of recombinant human erythropoietin. Perit Dial Int (1992) 1.34
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant (1995) 1.32
Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid (1997) 1.31
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf) (2001) 1.30
Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med (2011) 1.28
Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry (2000) 1.26
Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (1996) 1.25
Wound healing in cell studies and animal model experiments by Low Level Laser Therapy; were clinical studies justified? a systematic review. Lasers Med Sci (2002) 1.25
Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol (1997) 1.25
Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant (1990) 1.23
Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. Acta Paediatr (2004) 1.23
Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis (2000) 1.22
What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? J Neurol (2008) 1.21
Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke (1997) 1.21
Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int (1999) 1.20
The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting. Eur J Cancer (2004) 1.18
Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage. Intensive Care Med (2001) 1.17
Undertreatment of asthma in Dutch general practice. Fam Pract (1987) 1.16
The role of cognitive impairment in the quality of life after ischaemic stroke. J Neurol (1996) 1.15
Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant (1994) 1.13
The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease. Neurology (2007) 1.12
Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial (1999) 1.12
A circadian rhythm of proteinuria in patients with a nephrotic syndrome. Clin Sci (Lond) (1985) 1.11
The valuable contribution of observational studies to nephrology. Kidney Int (2007) 1.10
Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int (1997) 1.09
Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med (1997) 1.09
Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry (2006) 1.09
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice. Br J Cancer (2003) 1.08